McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
994.58
+13.70 (1.40%)
Oct 30, 2026, 4:00 PM EDT - Market closed
McKesson Financials Overview
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 410,983 | 403,430 | 359,051 | 308,951 | 276,711 | 263,966 |
Revenue Growth | 8.84% | 12.36% | 16.22% | 11.65% | 4.83% | 10.80% |
Gross Profit Gross Profit Growth | 14,933 | 14,527 | 12,937 | 12,584 | 12,229 | 13,084 |
Operating Income Operating Income Growth | 6,437 | 6,288 | 4,939 | 4,574 | 4,315 | 4,147 |
Net Income Net Income Growth | 4,592 | 4,762 | 3,295 | 3,002 | 3,560 | 1,114 |
Earnings Per Share EPS Growth | 37.48 | 38.38 | 25.72 | 22.39 | 25.03 | 7.23 |
EPS Growth | 50.20% | 49.22% | 14.87% | -10.54% | 246.30% | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
North American Pharmaceutical North American Pharmaceutical Growth | 340,696 | 336,652 | 304,507 | 261,368 | - | - |
Oncology & Multispecialty Oncology & Multispecialty Growth | 51,987 | 48,423 | 36,862 | 30,490 | - | - |
Prescription Technology Solutions Prescription Technology Solutions Growth | 5,937 | 5,805 | 5,216 | 4,769 | 4,387 | 3,864 |
Medical Surgical Solutions Medical Surgical Solutions Growth | 11,625 | 11,507 | 11,380 | 11,309 | 11,110 | 11,608 |
Other Segment Other Segment Growth | - | 1,043 | 1,086 | 1,015 | - | - |
Revenue (Total) Revenue (Total) Growth | 410,983 | 403,430 | 359,051 | 308,951 | 276,711 | 263,966 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 5,164 | 3,975 | 5,691 | 4,583 | 4,678 | 3,563 |
Total Debt Total Debt Growth | 11,796 | 8,786 | 7,432 | 7,426 | 7,313 | 7,617 |
Net Cash (Debt) Net Cash Growth | -6,632 | -4,811 | -1,741 | -2,843 | -2,635 | -4,054 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -54.13 | -38.77 | -13.59 | -21.20 | -18.53 | -26.31 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 6,853 | 6,155 | 6,085 | 4,314 | 5,159 | 4,434 |
Capital Expenditures CapEx Growth | -437 | -436 | -537 | -431 | -390 | -388 |
Free Cash Flow Free Cash Flow Growth | 6,416 | 5,719 | 5,548 | 3,883 | 4,769 | 4,046 |
Free Cash Flow Growth | 6.84% | 3.08% | 42.88% | -18.58% | 17.87% | -1.10% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 3.63% | 3.60% | 3.60% | 4.07% | 4.42% | 4.96% |
Operating Margin | 1.57% | 1.56% | 1.38% | 1.48% | 1.56% | 1.57% |
Pretax Margin | 1.57% | 1.54% | 1.21% | 1.23% | 1.67% | 0.73% |
Profit Margin | 1.12% | 1.18% | 0.92% | 0.97% | 1.29% | 0.42% |
FCF Margin | 1.56% | 1.42% | 1.54% | 1.26% | 1.72% | 1.53% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 3.760 | 3.170 | 2.750 | 2.400 | 2.090 | 1.830 |
Dividend Per Share Growth | 15.03% | 15.27% | 14.58% | 14.83% | 14.21% | 9.58% |
Dividend Yield | 0.38% | 0.36% | 0.41% | 0.44% | 0.58% | 0.58% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 26.53 | 22.26 | 25.60 | 23.50 | 13.70 | 41.17 |
Forward PE | 21.37 | 19.99 | 18.47 | 18.47 | 13.59 | 13.44 |
P/FCF Ratio | 18.07 | 18.53 | 15.20 | 18.17 | 10.22 | 11.33 |
PS Ratio | 0.28 | 0.26 | 0.24 | 0.23 | 0.18 | 0.17 |